๐ Statistics
- Analyst 1 Year Price Target:
-
- Upside/Downside from Analyst Target:
-
- Broker Call:
-
- Dividend Minimum 3 Year Yield:
4.75%
- EPS Growth Range (1Y):
100-200%
- Net Income Growth Range (1Y):
100-200%
- Revenue Growth Range (1Y):
<0%
-
Upcoming Earnings Date:
-
๐ฐ Dividend History
Current year to date yield:
0.00%
๐
SGX Earnings Announcements for 1B1
HC Surgical Specialists Limited (1B1)
Market: SGX |
Currency: SGD
Address: 233 River Valley Road
HC Surgical Specialists Limited, an investment holding company, provides medical services primarily in Singapore. The company provides endoscopic procedures, including gastroscopies and colonoscopies; and general surgery services with a focus on colorectal procedures in a network of clinics. It also offers treatment services for other conditions, such as haemorrhoids, anal fissure, hernia, anal abscess, cholecystitis, anal fistula, appendicitis, colorectal cancer, lipomas, cysts, and gastric cancer, vein laser vascular, laparoscopy, and other general and specialized medical services. In addition, the company provides orthopedic services comprising joint pain, sports injuries, osteoarthritis, rotator cuff tears, trigger finger, wounds/lumps, tenosynovitis, tunnel syndrome, bumps, joint replacement, arthroscopic surgery, knee osteotomy, realignment surgery, endoscopic spine surgery, disc replacements, spinal decompression, fractures, and orthobiologic injections. Further, it provides home care services, which include medical, nursing, physiotherapy, speech therapy, occupational therapy, and ambulance services; health screening, management of acute and chronic conditions, and pre-employment check-up; public health preparedness clinic scheme, swab and send home program, community health assist scheme, and COVID-19 swab test services. Additionally, the company offers diagnostic tests that comprise blood tests, X-Rays, ultrasound, CT scans, and MRIs. HC Surgical Specialists Limited was incorporated in 2015 and is based in Singapore.
Show more
๐ HC Surgical Specialists Limited Historical Chart
๐งพ Recent Financial Statement Analysis
January 13, 2026
HC Surgical Specialists Limited: Interim Financial Analysis โ HYFY2026 HC Surgical Specialists Limited (HCSS), a Singapore-listed medical services group operating 18 clinics across the island, has released its condensed interim financial statements for the six months ended 30 November 2025…
January 13, 2026
HC Surgical Specialists Limited HYFY2026 Results: In-depth Analysis for Investors HC Surgical Specialists Limited Delivers Strong HYFY2026 Profit Growth and Declares Interim Dividend Key Highlights for Investors Profit to Shareholders up 17.5% YoY: HC Surgical Specialists Limited ("HCSS") posted a…
October 21, 2025
HC Surgical Specialists Reveals Strategic Growth Plans, Dividend Policy Updates, and Post-Suspension Recovery at AGM: What Investors Must Know Key Takeaways from HC Surgical Specialists' 2025 Annual General Meeting HC Surgical Specialists Limited (SGX: 1B1), a leading provider of endoscopic…
January 14, 2025
HC Surgical Specialists Announces Interim Dividend and Record Date HC Surgical Specialists Announces Interim Dividend and Record Date Singapore โ HC Surgical Specialists Limited has officially announced the details of its interim dividend for the financial year ending 31 May…
๐ View more in SGX corporate News ๐ View more in SGX Financial statements
๐ฐ Related News & Research
Showing results matched by any of: 1B1, HC Surgical Specialists Limited, HC Surgical, HSP SP, HC SURGICAL SPECIALISTS LTD, HC SURGICAL SPECIALISTS
January 13, 2026
HC Surgical Specialists Limited: Interim Financial Analysis โ HYFY2026 HC Surgical Specialists Limited (HCSS), a Singapore-listed medical services group operating 18 clinics across the island, has released its condensed interim financial statements for the six months ended 30 November 2025…
January 13, 2026
HC Surgical Specialists Limited HYFY2026 Results: In-depth Analysis for Investors HC Surgical Specialists Limited Delivers Strong HYFY2026 Profit Growth and Declares Interim Dividend Key Highlights for Investors Profit to Shareholders up 17.5% YoY: HC Surgical Specialists Limited ("HCSS") posted a…
October 21, 2025
HC Surgical Specialists Reveals Strategic Growth Plans, Dividend Policy Updates, and Post-Suspension Recovery at AGM: What Investors Must Know Key Takeaways from HC Surgical Specialists' 2025 Annual General Meeting HC Surgical Specialists Limited (SGX: 1B1), a leading provider of endoscopic…
January 14, 2025
HC Surgical Specialists Announces Interim Dividend and Record Date HC Surgical Specialists Announces Interim Dividend and Record Date Singapore โ HC Surgical Specialists Limited has officially announced the details of its interim dividend for the financial year ending 31 May…